According to the letter, the company lacked a testing protocol to ensure all devices met pre-determined design specifications and failed to validate the effect of manufacturing operations that incorporate metallic spikes into Trilogy devices.
As a result, the Puerto Rico facility has been temporarily closed as Zimmer works to implement the FDA-mandated processes.
More Articles on Orthopedic Devices:
8 New Orthopedic & Spine Device Launches
Mazor Robotics Finalizes Financing Agreement for Up To $15M
Spinal Elements to Launch Hero Allograft
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
